DOPAMINE D4 RECEPTOR GENE EXON III POLYMORPHISM AND INTERINDIVIDUAL VARIATION IN RESPONSE TO CLOZAPINE

REFERENCES

• Adamson M. D., Kennedy J., Petronis A., Dean M., Virkkunen M., Linnoila M., Goldman D. DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls. American Journal of Medical Genetics 1995; 60(3)199–205, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Cohen B. M., Ennulat D. J., Centorrino F., Matthysse S., Konieczna H., Chu H. M., Cherkerzian S. Polymorphisms of the dopamine D4 receptor and response to antipsychotic drugs. Psychopharmacology (Berlin) 1999; 141(1)6–10, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Crow T. J. The two-syndrome concept: Origins and current status. Schizophrenia Bulletin. 1985; 11: 471–486, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaiser R., Konneker M., Henneken M., Dettling M., Muller-Oerlinghausen B., Roots I., Brockmoller J. Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotie treatment, but association with catatonic schizophrenia. Molecular Psychiatry 2000; 5(4)418–424, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry 1988; 45(9)789–796, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kay S. R., Fisbein A., Opler L. A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987; 13(2)261–276, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kennedy J. L. Prediction of neuroleptic response: Genetic strategies. Prediction of neuroleptic treatment outcome in schizophrenia: Concepts and methods, W. Gaebel, A. G. Awad. Springer-Verlag, Wien 1994; pp. 147–154
   Google Scholar
• Kerwin R. W., Pilowsky L., Munro J., Shaikh S., Gill M., Collier D. Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors. Journal of Clinical Psychiatry 1994; 55(Suppl B)57–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kohn Y., Ebstein R. P., Heresco-Levy U., Shapira B., Nemanov L., Gritsenko L., Avnon M., Lerer B. Dopamine D4 receptor gene polymorphisms: Re drd4 gene and response to clozapine lation to ethnicity, no association with schizophrenia and response to clozapine in lsraeli subjects. European Journal of Neuropsychopharmacology 1997; 7(1)39–43, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lichter J. B., Barr C. L., Kennedy J. L., Van Tol H. J. M., Kidd K. K., Livak K. J. A hypervariable segment in the human dopamine receptor (DRD4) gene. Human Molecular Genetics 1993; 2(6)767–773, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lung F. W., Tzeng D. S., Shu B. C. Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia. Schizophrenia Research 2002; 57(2–3)239–245, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Masellis M., Basile V. S., Ozdemir V., Meltzer H. Y., Macciardi F. M., Kennedy J. L. Pharmacogenetics of antìpsychotic treatment: Lessons learned from clozapine. Biological Psychiatry 2000; 47(3)252–266, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Meltzer H. Y. Role of serotonin in the action of atypical antipsychotic drugs. Clinical Neuroscience 1995; 3(2)64–75, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Meltzer H. Y. The role of serotonin in antipsychotie drug action. Neuropsychopharmacology 1999; 21(2 Suppl)106–115, [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Potkin S. G., Bera R., Gulasekarani B., Costa J., Hayes S., Jin Y., Richmond G., Carreon D., Sitanggan K., Gerber B. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Journal of Clinical Psychiatry 1994; 55(9, suppl B)133–136, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Propping R., Nöthen M. M. Genetic variation of CNS receptorsa new perspective for pharmacogenetics. Pharmacogenetics 1995; 5(5)318–325, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Rao P. A., Pickar D., Gejman P. V., Ram A., Gershon E. S., Gelernter J. Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Archives of General Psychiatry 1994; 51(11)912–917, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rietschel M., Naber D., Oberlander H., Holzbach R., Fimmers R., Eggermann K., Moller H. I., Propping P., Nöthen M. M. Efficacy and side-effects of clozapine: Testing for association with allelic variation in the dopamine D4 receptor gene. Neuropsychopharmacology 1996; 15(5)491–496, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shaikh S., Collier D. A., Sham P., Pilowsky L., Sharma T., Lìn L. K., Crocq M. A., Gill M., Kerwin R. Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients. American Journal of Medical Genetics 1995; 60(6)541–545, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schulte P. What is an adequate trial with clozapine?: Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia. Clinical Pharrna-cokinetics 2003; 42: 607–618, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Van, Tol H. H., Bunzow J. R., Guan H. C., Sunahara R. K., Seeman P., Niznik H. B., Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic elozapine. Nature 1991; 350(6319)610–614, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Van, Tol H. H., Wu C. M., Guan H. C., Ohara K., Bunzow J. R., Civelli O., Kennedy J., Seeman P., Niznik H. B., Jiovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 1992; 358(6382)149–152, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar